Texas Retina Opens Eight New Clinical Trials
At Texas Retina, we are committed to conducting ongoing research that could improve care for our patients — a value instilled by the pioneering physicians who founded our practice more than 50
read more
Dr. Abbey Presents ARCHER II Clinical Trial Data at The Retina Society Annual Scientific Meeting
Texas Retina’s Ashkan Abbey, MD, presented baseline characteristics of participants in the Phase 3 ARCHER II clinical trial for geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD) at the 59th
read more
A New Way to Explore Career Opportunities at Texas Retina
Texas Retina has launched a new Careers page to make it easier to learn about career opportunities and current openings within our organization. For more than six decades, Texas Retina has brought
read more
Dr. Abbey Receives 2026 Achievement Award from the American Academy of Ophthalmology
Texas Retina’s Ashkan M. Abbey, MD, has earned the 2026 Achievement Award from the American Academy of Ophthalmology (AAO) in recognition of his contributions to the Academy, its scientific and educational programs,
read more
When Should You See a Retina Specialist?
Your ophthalmologist or optometrist can monitor your vision, prescribe glasses and contact lenses, and diagnose, treat and prevent a number of eye diseases. However, for some eye conditions, your eye doctor may
read more Dr. Abbey Discusses the Use of VABYSMO® for Polypoidal Choroidal Vasculopathy
In the current issue of Ocular Surgery News on Healio, Texas Retina’s Ashkan M. Abbey, MD, shares his perspective on the recently reported two-year results from the Phase 3b/4 SALWEEN study evaluating
read more
Dr. Choi Develops New Surgical Technique for Macular Holes That Fail to Close After Initial Surgery
Texas Retina’s Rene Y. Choi, MD, PhD, recently published a case report in the medical journal Retinal Cases & Brief Reports describing a surgical technique he developed to treat macular holes that
read more
September is Sports Eye Safety Month
According to Prevent Blindness, there were more than 44,000 sports-related eye injuries treated in the United States in 2025. Basketball had the highest rate of eye injuries for those ages 15 and
read more
Texas Retina Dallas Research Team Recognized for Highest Site Enrollment Globally in Geographic Atrophy Clinical Trial
Under the leadership of Principal Investigator Dr. Ashkan M. Abbey, the Texas Retina Dallas research team was recently named the top enroller for Part I of the DFI18231 study, which is evaluating
read more
National Retina Research Network Invites Dr. Shami to Discuss Current Study Protocols
The U.S.-based, federally funded DRCR Retina Network recently invited Texas Retina’s Michel J. Shami, MD, to provide investigators with updates on three of the network’s current studies: Protocol AF: A randomized trial
read more